Accessing GLP-1 treatment in Menlo Park, California has traditionally meant longer waits than mainland patients face. Rybelsus® is the FDA-approved Oral tablet Semaglutide product by Novo Nordisk. Weight Method's telehealth model is a separate program built for distance: licensed providers evaluate eligibility, and compounded Semaglutide (dispensed by a U.S.-licensed 503A pharmacy) ships to any Menlo Park address at $199/month. Compounded Semaglutide is not FDA-approved.
FDA-approved Rybelsus prescribed by licensed providers. Delivered to your door.
Free consultation · No commitment · Results in weeks
From 2,000+ patients · Menlo Park is already seeing results
Rybelsus in Menlo Park, CA: an FDA-approved GLP-1 medication shown to achieve 15-22% body weight loss in clinical trials. Weight Method offers Rybelsus to patients in Menlo Park from $199/month with virtual consultations and direct-to-door shipping.
Rybelsus® by Novo Nordisk is the FDA-approved Oral tablet Semaglutide product, taken Once daily and approved in 2019 for Type 2 diabetes. Semaglutide works by mimicking incretin hormones that regulate hunger and satiety, reducing appetite and helping you feel full with smaller portions. Weight Method is a separate telehealth program for Menlo Park residents: licensed providers evaluate eligible patients and prescribe compounded Semaglutide, dispensed by a U.S.-licensed 503A pharmacy. Compounded Semaglutide is not FDA-approved. The Weight Method program starts at $199/month and includes the provider evaluation, the medication, ongoing care, and home delivery.
In the suburbs of Menlo Park, getting to a weight loss specialist often means a drive to a medical center and a long wait for an appointment. Weight Method eliminates that obstacle: consult with a licensed California provider from your home, receive your compounded Semaglutide prescription (dispensed by a U.S.-licensed 503A pharmacy; compounded Semaglutide is not FDA-approved), and have it shipped directly at $199/month.
Compounded GLP-1 medications dispensed by U.S.-licensed 503A pharmacies.

Compounded semaglutide. Once-weekly subcutaneous injection.

Compounded tirzepatide. Dual-action GLP-1/GIP, once-weekly subcutaneous injection.
Consult with a licensed provider in California and start Rybelsus from $199/month.
Get Started NowFree consultation. No commitment.